Maberley, David A L http://orcid.org/0000-0001-6237-1964
Beelen, Maarten
Smit, Jorrit
Meenink, Thijs
Naus, Gerrit
Wagner, Clemens
de Smet, Marc D
Article History
Received: 15 October 2019
Revised: 17 January 2020
Accepted: 27 January 2020
First Online: 3 February 2020
Compliance with ethical standards
:
: David Maberley has recently conducted phase 3 trials for Alcon, Roche, Abvie, and Ophthotech and declares no other conflicts of interest related to this study. Maarten Beelen, Jorrit Smit, Thijs Meenink, and Gerrit Naus are employees of Preceyes B.V., Eindhoven, The Netherlands, and declare no other conflicts of interest. Clemens Wagner is an employee of VRmagic Holding AG, Mannhein, Germany, and declares no other conflict of interest. Marc de Smet is Chief Medical Officer of Preceys B.V., Eindhoven, The Netherlands, and of Oxular Ltd.; he has received honoraria from Allergan, has been a part of advisory boards for Abbvie, Allergan, and Janssen and declares no other relevant conflicts of interest.
: All surgeons consented to the use their surgical data for research purposes. This study conforms to the 1964 Declaration of Helsinki and its later amendments. IRB/Ethics Committee approval was not required for this study as there were no human or animal subjects. Exemption has been confirmed by the Central Committee on Research Involving Human Subjects (CCMO), The Hague, Netherlands.